Snehaa Organics IPO allotent likely today. Here’s how to check status

The allotment of shares for Sneha Organics’s Rs 33 crore IPO is expected to be finalized on Wednesday. Investors who applied to the issue can soon check whether they have been allotted shares through the registrar’s portal.

How to check allotment status

Investors can check their allotment status on the website of the registrar, Skyline Financial Services, once the allotment is finalized. The following steps can be followed:

Visit Skyline Financial Services’ IPO allotment page (https://www.skylinerta.com/ipo.php).

Select "Snehaa Organics IPO" from the dropdown.

Enter your PAN or application number.

Click on "Search" to view your allotment status

IPO details and subscription

The public issue opened on August 29 and closed on September 2. Priced in the band of Rs 115–Rs 122 per share, the IPO consisted entirely of a fresh issue of 26.79 lakh shares.

Also Read: From boAt to Urban Company: Sebi approves 13 IPOs in a week as markets brace for listing deluge

The demand for the public offer was decent with nearly 28 times subscription. The retail category saw the strongest response, booked 37.75 times, while Qualified Institutional Buyers (QIBs) subscribed 42.19 times their quota. Non-institutional investors (NIIs) put in bids 16.23 times their reserved portion.

Snehaa Organics GMP

Ahead of listing, the stock is trading at a GMP of Rs 3 per share, or about 3% over the issue price. This suggests a muted debut, with the listing price likely to be around Rs 125. The premium indicates some positive sentiment but remains modest compared to highly oversubscribed SME issues in recent weeks.

Allottees will see the number of shares credited to their demat account. Refunds for non-allottees will be initiated from September 4, and shares will be credited to successful bidders on the same date. The stock will list on NSE SME on September 5.

Company profile and financials

Hyderabad-based Snehaa Organics is engaged in solvent recovery and recycling, serving industries such as pharmaceuticals. Financially, it has shown sharp growth. Revenue rose 10% to Rs 26.29 crore in FY25, while net profit more than doubled to Rs 7.34 crore.

IPO proceeds will go towards working capital requirements, loan repayment, and general corporate purposes.

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)